JAKARTA. PT Pyridam Farma Tbk sets the target of sales growth to 50% this year. This surge is expected to be led by the launch of several top products.
Corporate Communication Manager of Pyridam Farma, Kezia Mareshah, claimed that in order to maximise the business this year, PYFA would actively generate new finest products, including innovative products and products relevant to Indonesian’s needs. In regard to the said strategy, PYFA will enhance its research and development (R&D) sector, collaborating with various pharmaceutical companies within the country and beyond, as Mareshah explained to Kontan earlier this week.
Mareshah also revealed that business lines of PYFA would introduce fresh products this year. They lines in question include the prescription drugs division, the consumer health division (PYFAhealth and PYFAaesthetic), and the medical devices division.
In the PYFAhealth business line, the company will release Vitamin E 100 IU, and multivitamins & mineral. Both products will add to the four previously launched variants in December 2021. (AM/ZH)